4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-060395
SVP and General Counsel sold 2,880 shares at an average $46.31 ($133,359)
- SVP and General Counsel acquired 2,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Taylor Stacy L · SVP and General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-23 | Exercise or conversion : show line 1 in the form | +1,109 | $7.80 | $8,650 | 2,409 | D |
| 2020-11-23 | Exercise or conversion : show line 2 in the form | +1,771 | $6.55 | $11,600 | 4,180 | D |
| 2020-11-23 | Sale : show line 3 in the form | −23 | $45.69 | $1,051 | 4,157 | D |
| 2020-11-23 | Sale : show line 4 in the form | −2,857 | $46.31 | $132,308 | 1,300 | D |
| Open-market sales · 2,880 sh · avg $46.31 · $133,359 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-23 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,109 | 33,926 | D |
| 2020-11-23 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −1,771 | 28,334 | D |
Loading xslF345X03/doc4.xml…